Otonomy Receives FDA Clearance of Investigational New Drug Application for Tinnitus Product Candidate, OTO-311

SAN DIEGO, Oct. 5, 2015 -- (Healthcare Sales & Marketing Network) -- Otonomy, Inc. (OTIC), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the ear, today a... Biopharmaceuticals, FDAOtonomy, OTO-311, tinnitus
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news